Non-inferiority of intermittent theta burst stimulation over the left V1 vs. classical target for depression : A randomized, double-blind trial
Copyright © 2023 Elsevier B.V. All rights reserved..
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) targeting the visual cortex (VC) has shown antidepressant effects for major depressive disorder (MDD) in sham-controlled trials, but comparisons with rTMS targeting the left dorsolateral prefrontal cortex (DLPFC) are lacking. We aimed to determine the non-inferiority of intermittent theta-burst stimulation (iTBS) over VC vs DLPFC for MDD.
METHODS: Participants randomly received navigated iTBS over the left V1 or the left DLPFC twice daily for 14 days with a 3-month follow-up. The primary outcome was change in Hamilton Depression Rating Scale (HAMD-17) score from baseline to treatment end, with 2.5 points as the non-inferiority margin. Secondary outcomes included: improvement in Montgomery-Asberg Depression Rating Scale (MADRS), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA); response and remission rates; suicidal ideation and adverse events.
RESULTS: Of 75 randomized patients, 67 completed full treatment, including 52 first-episode patients and 15 relapsers. The primary outcome indicated the non-inferiority of VC (adjusted difference 1.14, lower 97.5 % CI -1.24; p = .002), confirmed by improvements in objective cognitive task and protein levels, as did most secondary outcomes. Reduced suicidal ideation after treatment, incidence of eye discomfort and pain score were lower in the VC group.
CONCLUSIONS: Left VC iTBS has the potential to be non-inferior to DLPFC iTBS in most first-episode MDD in improving depressive symptoms and cognitive function, with less suicidal ideation and adverse events.
LIMITATIONS: Given the limited sample size, the lack of a sham control and the use of antidepressants, the findings should be interpreted with caution.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:343 |
|---|---|
| Enthalten in: |
Journal of affective disorders - 343(2023) vom: 15. Dez., Seite 59-70 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kong, Yan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarker |
|---|
| Anmerkungen: |
Date Revised 16.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jad.2023.09.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362481369 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362481369 | ||
| 003 | DE-627 | ||
| 005 | 20231226091332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jad.2023.09.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1208.xml |
| 035 | |a (DE-627)NLM362481369 | ||
| 035 | |a (NLM)37751801 | ||
| 035 | |a (PII)S0165-0327(23)01162-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kong, Yan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Non-inferiority of intermittent theta burst stimulation over the left V1 vs. classical target for depression |b A randomized, double-blind trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) targeting the visual cortex (VC) has shown antidepressant effects for major depressive disorder (MDD) in sham-controlled trials, but comparisons with rTMS targeting the left dorsolateral prefrontal cortex (DLPFC) are lacking. We aimed to determine the non-inferiority of intermittent theta-burst stimulation (iTBS) over VC vs DLPFC for MDD | ||
| 520 | |a METHODS: Participants randomly received navigated iTBS over the left V1 or the left DLPFC twice daily for 14 days with a 3-month follow-up. The primary outcome was change in Hamilton Depression Rating Scale (HAMD-17) score from baseline to treatment end, with 2.5 points as the non-inferiority margin. Secondary outcomes included: improvement in Montgomery-Asberg Depression Rating Scale (MADRS), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA); response and remission rates; suicidal ideation and adverse events | ||
| 520 | |a RESULTS: Of 75 randomized patients, 67 completed full treatment, including 52 first-episode patients and 15 relapsers. The primary outcome indicated the non-inferiority of VC (adjusted difference 1.14, lower 97.5 % CI -1.24; p = .002), confirmed by improvements in objective cognitive task and protein levels, as did most secondary outcomes. Reduced suicidal ideation after treatment, incidence of eye discomfort and pain score were lower in the VC group | ||
| 520 | |a CONCLUSIONS: Left VC iTBS has the potential to be non-inferior to DLPFC iTBS in most first-episode MDD in improving depressive symptoms and cognitive function, with less suicidal ideation and adverse events | ||
| 520 | |a LIMITATIONS: Given the limited sample size, the lack of a sham control and the use of antidepressants, the findings should be interpreted with caution | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biomarker | |
| 650 | 4 | |a Emotional Stroop task | |
| 650 | 4 | |a Intermittent theta burst stimulation | |
| 650 | 4 | |a Major depressive disorder | |
| 650 | 4 | |a Non-inferiority trial | |
| 650 | 4 | |a Protein | |
| 650 | 4 | |a Visual cortex | |
| 700 | 1 | |a Zhou, Jiawei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Mingge |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yuhua |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Tingting |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Zhi |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Zhenghua |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Yonggui |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Liangliang |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Ruize |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Yachen |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Haixia |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zhijun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of affective disorders |d 1989 |g 343(2023) vom: 15. Dez., Seite 59-70 |w (DE-627)NLM000465615 |x 1573-2517 |7 nnns |
| 773 | 1 | 8 | |g volume:343 |g year:2023 |g day:15 |g month:12 |g pages:59-70 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jad.2023.09.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 343 |j 2023 |b 15 |c 12 |h 59-70 | ||